Animal models of murine respiratory mycoplasmosis due to Mycoplasma pulmonis provide excellent opportunities to study respiratory disease due to an infectious agent. The purpose of the present study was to develop and characterize an aerosol model for the production of murine respiratory mycoplasmosis in mice. The exposure of mice for 30 min to aerosols generated with a DeVilbiss 45 nebulizer in a nose-only inhalation chamber consistently reproduced typical lesions. The chamber was operated with a nebulizer air flow of 5.3 liters/min at 5.0 lb/in2 and a diluting air flow of 20 liters/min, with the nebulizer containing 5 ml of a suspension of viable M. pulmonis organisms (a concentration between 6 x 105 to 6 x 1010 CFU/ml). Infective aerosol particles of less than a 4.0-p.m median aerodynamic diameter with a geometric standard deviation of approximately 2.0 reached the lungs and were evenly distributed among the different lung lobes. A minimum 1.5-log loss of viability in the M. pulmonis suspension was demonstrated. With the exception of the 50% lethal dose, all of the parameters previously established by intranasal inoculation could be examined with the aerosol model. The major advantages of the aerosol model were excellent reproducibility of exposure (both between different experiments and between animals in a given experiment), the avoidance of anesthetization, and the ability to immediately deposit the majority of the organisms in the lung. The only disadvantage was the requirement for large volumes of mycoplasmal cultures.
Murine respiratory mycoplasmosis (MRM) due to Mycoplasma piulmonis is one of the most common and economically important diseases of the respiratory tract of laboratory rats and mice (5) . Although naturally occurring MRM is potentially devastating to respiratory research involving mice or rats, animal models of experimentally induced MRM are excellent for the study of respiratory disease induced by an infectious agent (5, 16) . M. pulinonis alone can produce all of the lesions of the naturally occurring respiratory disease; however, one of the striking features of the experimental disease in both rats and mice is the extreme variability in the incidence, severity, and extent of both upper-tract and lung lesions after experimental infection via intranasal inoculation (6) . This variability is seen even when care is taken to minimize the effects of intrinsic and extrinsic factors such as age (4) , genetic constitution (7, 9) , and levels of intracage ammonia (3), all of which are known to markedly influence disease incidence and severity. Reduction of this variability would significantly simplify experiments designed to elucidate the mechanisms by which lesions develop.
One major source of variation in intranasal inoculation is the proportion of the inoculum which actually reaches the lungs. This proportion can be affected by such factors as the depth and type of anesthesia and the volume inoculated. Lightly anesthetized animals often swallow part of the inoculum; in addition, many anesthetics affect pulmonary defense mechanisms (11) . In hamsters intranasally inoculated with 2, 20, or 200 ,ul of Mycoplasma pneumtnoniae (with the concentration adjusted to give the same total dose per animal), only the largest volume resulted in the deposition of the organisms in the lungs (14) . The two smaller doses, as * Corresponding author.
well as a large-particle aerosol (with a mass median aerosol
[particle] diameter of 8 pLm), gave only upper-tract colonization. Interestingly, the use of a small-particle aerosol (with a mass median diameter of 2.3 VLm) also produced infection in the lungs.
An aerosol exposure should more closely mimic the mode of transmission thought to be most important in naturally occurring MRM (15) . Infection by exposure to aerosols has led to highly reproducible models with other bacteria, with relatively small variation in the initial doses among animals (22) . The use of aerosolization as the method of exposure also avoids the use of anesthetic agents. The purpose of the present studies was to develop and characterize an aerosol model for the production of MRM in mice. The reproducibility of aerosol production, the initial deposition in various body organs, and the lung lesions produced were examined in mouse strains resistant (C57BL/6N) and susceptible (C3H/HeN) to MRM (9) . Although there were no differences in the sites of initial deposition or in the initial numbers of organisms deposited in the lungs, there was a marked difference between the two mouse strains in the production of lesions.
MATERIALS AND METHODS
Mycoplasmas. Initial experiments were performed by thawing frozen aliquots (-70°C) of a stock culture of M. pilmnonis CT and growing them for 12 h in fresh mycoplasma broth (9) to avoid the viability loss (approximately 1 log drop in CFU) due to freezing. Growth for 12 h consistently gave rise to a culture in the mid-log phase of growth. Strain CT was originally isolated from a mouse with natural MRM and was identified as a pure culture of M. piilmonis by immunofluorescence (10 (13, 19 ) equipped with a model 45 nebulizer (DeVilbiss Health Care Division, Somerset, Pa.) was used to generate Al. pilinoniis aerosols for most studies (Fig. 1) . The nose-only chamber hasn72 ports, 36 on each side, to which animal tubes are attached via brass fittings with 0 rings. The chamber was operated with a nebulizer air flow of 5.3 liters/min at 5.0 lb/in2, with the nebulizer containing 5 (1) . The impactors separate particles based on their aerodynamic diameter, which is the diameter of a unit density sphere with the same settling velocity. The inertia of the particle through a jet is used to cause separation of the particle from the air stream, resulting in impaction of the particle on a preweighed glass coverslip for the liters/min, the distribution of CFU-containing particles could not be determined during an actual experiment with the animals. To sample with the Andersen impactor, we diverted the entire aerosol stream from the inhalation chamber to the impactor inlet. The drying time for the aerosol and the distance it traveled were shortened slightly by this necessity. Thus, the Mercer impactor samples the aerosol just downstream of the animal exposure block; the Andersen impactor samples the aerosol just upstream of the block. The particles sampled at the two sites should be of comparable size, which should not be significantly affected by passage of the aerosol through the exposure block. During experiments when the total aerosol flow was less than 28 liters/min, the effective cutoff diameter of the stages was recalculated based on the experimental flow rate.
The size distribution data were determined by a plot of the percentage (mass, radioactivity, or CFU) less than that of the effective cutoff particle diameter against the log of the effective cutoff particle diameter. The least-squares regression line from these data was used to obtain the median aerodynamic particle diameter and ug of the size distribution. The cumulative percentage less than that of a specific aerodynamic particle diameter is also available from this analysis and can be used in estimating regional deposition in the airways.
A Midget impinger (Ace Glass, Vineland, N.J.), was used to collect air samples (25) at two points (directly after the nebulizer and at the animal port) in the aerosolization system to determine the loss of viability by comparing the disintegrations per minute/CFU ratio. The loss of viability directly after the nebulizer could be taken to represent mycoplasmal killing due to the nebulization process and was primarily caused by the shear forces generated at the nebulizer orifice. The loss of viability measured at the animal port represented the loss of viability due to both shear forces and desiccation after the mixing of air from the nebulizer with diluting air.
Animals. All of the mice used in these studies were 6-to 10-week-old, pathogen-free C57BL/6N and C3H/HeN mice from breeding colonies maintained at the University of Alabama at Birmingham. The colonies were monitored monthly by serology (9) and quarterly by culture and histology for the presence of mycoplasmas and other murine pathogens and have consistently been negative for all pathogens for the past 3 years. Experimental mice were maintained in Trexler-type plastic film isolators in sterile shoebox cages before their exposure to M. pulmonis in the aerosol chamber and in sterile shoebox cages equipped with filter tops after exposure. All cages were provided with sterile hardwood chip bedding (P. J. Murphy Forest Products, Rochelle Park, N.J.); sterile food (Agway, Inc., Syracuse, N.Y.) and sterile water were provided ad libitum. The level of intracage ammonia was measured during experiments and was consistently less than 25 ppm (0.025 ml/liter) (3).
Quantitation of M. pulmonis in tissues. Quantitative mycoplasma cultures of various organs were performed as described previously (9) . In brief, selected tissues (nasal Viability of aerosolized M. pulmonis. Two factors may cause the loss of viability of mycoplasmas during aerosolization: (i) the subjection (by nebulization) of the organisms to shear forces during the production of aerosol droplets and (ii) the desiccant effect of diluting air after nebulization. A midget impinger was used to collect a sample from the chamber to measure the disintegrations per minute/CFU ratio during the aerosolization of approximately 5 ml containing 108 CFU of 35S-labeled M. pidlinion)is per ml at approximately 106 dpm/ml. The chamber was operated under the standard conditions of a diluting air flow of 20 liters/min, a nebulizer air flow of 5.3 liters/min. Initial studies showed an average loss in viability of 4 + 0.45 logs between the disintegrations per minute/CFU ratio in the nebulizer and that from a sample taken immediately after nebulization (based on three experiments).
The effects of replacement of the mycoplasmal suspension in the nebulizer every 5 min during a run were determined in an experiment identical to the one above. With replacement, there was a loss of viability of only 1.5 + 0.2 logs during nebulization (based on three experiments). The greater loss of viability seen with an unreplenished mycoplasmal suspension was likely the result of the aforementioned shear forces. Particles not escaping into the aerosol during nebulization fall back into the suspension. As nebulization proceeds, a lower percentage of organisms in the suspension are viable. The replenishment of the suspension increases the percentage of viable organisms in the nebulizer and the numbers of viable mycoplasmas in the aerosol. With the placement of the impinger at the level of the animal port, with the standard conditions of a diluting air flow of 20 liters/min and a nebulizer air flow of 5.3 liters/min, and with approximately the same concentrations of radiolabeled organisms as in the above experiments, there averaged less than a 1-log loss in viability between particles leaving the nebulizer and those reaching the nose-only port (data not shown) whether the diluting air flow was 20 or 11 liters/min (based on three experiments each).
Variability due to chamber position. Because the location of animals in the nose-only chamber might affect the dose of organisms received, 2-to 3-month-old C3H/HeN mice were exposed for 30 min to aerosols generated by nebulizing 5 ml of RPMI containing 2.5 x 108 CFU of radiolabeled M. plulnlioniis per ml at a nebulizer pressure of 5 lb/in2, a diluting air flow of 20 liters/min, and a nebulizer air flow of 5.3 liters/min. The median aerodynamic particle diameter as determined by radioactivity was 1.22 ,um ((Tg, 2.66). After exposure, the animals were killed and the amount of radio- activity per animal was determined by counting the amount of label in the nasal passages, larynx, trachea, lungs, and upper gastrointestinal tract. Because variation between positions must be considered in relationship to variation between animals, the data were analyzed to determine variation by animal and location. There was a 16% variation among animals in the total amount of radioactivity recovered (the average recovery per animal was 836 dpm per animal with a standard deviation of 122). To determine the amount of the total variation due to chamber position, we plotted the total radiolabel counts against chamber positions and performed correlation analysis. A scatter diagram of chamber positions and amounts of radioactivity per animal is shown in Fig. 3 . The correlation coefficient was -0.15, indicating no significant degree of correlation between dose and chamber position.
Distribution of M. pulmonis among various tissues after exposure to infective aerosols. To determine the initial deposition of M. pulmonis in aerosol-exposed mice and any difference between individual strains of mice, we exposed six C3H/HeN and six C57BL/6N mice (8 to 10 weeks old for both strains) to aerosols generated with approximately 2 x 108 CFU of viable radiolabeled organisms per ml in the nebulizer. The median aerodynamic particle diameter as determined by radioactivity was 1.28 ± 0.08 ,um (org, 2.98 ± 0.45). Immediately after removal from the aerosolization chamber, all animals were killed, and the amount of radioactivity and number of viable organisms were determined for the nasal passages, oropharynx, larynx, trachea, lungs (and each lung lobe), and upper gastrointestinal tract. The experiment was repeated twice, and because of day-to-day variation in labeling efficiency, the data for radiolabel distribution were expressed as percentages of the total received by the animal (Fig. 4 and 5 ). There were no significant differences between the two strains in the initial deposition of the radiolabel in any location. For both strains, a large percentage of the total dose was deposited in the lung and was evenly distributed among the lobes (Table 2) relative to the proportional weights of the different lobes. The culture data are similar, whether expressed as the total number of organisms or the percentage of the total number received per mouse (data not shown). Establishment of MRM by aerosol exposure. Initial attempts to establish MRM by the exposure of mice to M. pulmonis aerosols were unsuccessful even though culture data indicated that more organisms were in the lungs than the PD50 determined by intranasal inoculation for either C3H/HeN or C57BL/6N mice (9) . This necessitated the lungs of the animals at time zero (within 30 min after the end of aerosol exposure) are given in Table 3 . (The experiment was repeated to yield a total of six animals per group.) There was no significant difference in the number of organisms cultured from the lungs for the two strains; however, C57BL/6N mice had significantly more M. piilinonis cultured from the nasal passages at time zero (P = 0.02 for the log1(10 dose group) (Fig. 6 ). The incidences of death, gross pneumonia, microscopic lesions, and infection after 7 days are given in Table 4 . The PD5(s, as well as the micoscopic lesion doses and ID50s for lungs and nasal passages, are shown in Table 5 . The PD50 was determined in two additional experiments for both strains and averaged 1.37 x 108 ± 1.70 x 108 CFU in C3H/HeN mice and 1.54 x 10±( + 1.16 x 10'( CFU in C57BL/6N mice. The 2-log difference in the PD50 between the two strains was constant each time this parameter was determined.
The lesions produced were typical of MRM and were more extensive in C3H/HeN mice than in C57BL/6N mice, as has been reported after intranasal inoculation (9) . The numbers of organisms actually recovered by quantitative cultures from the lungs and nasal passages of each group of animals are shown in Fig. 7 DISCUSSION This study shows that the establishment of MRM by the aerosolization of M. pulmonis is feasible and relatively easily standardized. The variability due to aerosolization as determined by the median aerodynamic particle diameter and ag, the amount of radiolabel deposited in various tissues, and the CFU of bacteria that can be cultured from the respiratory tract is considerably smaller than the animal-to-animal variability in disease susceptibility (as seen in incidence figures for gross and microscopic lesions). Interestingly, the data in these studies indicate that even between resistant and susceptible strains, there is little difference in susceptibility to the establishment of infection. Furthermore, there is no difference between the two mouse strains in the initial localization of the organisms in the lungs. Surprisingly, the resistant strain had more organisms in the nasal passages at the beginning of the experiment. However, the variability both between strains and within a strain was associated with the number of organisms found at 7 days postexposure and with lesion production, probably due to nonspecific host defenses. A possible explanation for the difference between the two strains in susceptibility to lesions is that C57BL/6N mice may have more efficient pulmonary clearance mechanisms that limit the degree of infection more effectively.
The inability to directly determine the number of organisms inhaled prevents direct correlation between biological endpoints established previously by intranasal (9) and aerosol infections. However, comparison of the differences previously seen with C3H/HeN and C57BL/6N mice after the intranasal inoculation of M. pulmonis and those in the present studies show an almost identical relationship: there is approximately a 2-log difference in the PD50 and a 1-log difference in the ID50 (for the lungs) between the two strains regardless of the method of infection.
The establishment of mycoplasmal respiratory diseases by aerosol models has previously been reported only for M. pneumoniae in hamsters (13, 14) . Using this model, Jemski et al. showed that small particles (<5 ,um) are required to establish an infection in the lung by exposure to infective aerosols (14) . Our data suggest that lower-tract infection and disease in mice are also readily established by particles of approximately 1.5 to 2.0 plm and thereby support the conclusions of Jemski et al.
Hu et al. reported a 55% survival rate for aerosolized M. pneumoniae (13) . This is considerably more than the minimum of a 1.5-log viability drop seen in our studies, with the majority of the viability drop occurring during nebulization. This difference is not readily explained, because insufficient data are presented in the paper of Hu et al. concerning the method by which survival was calculated. Perhaps M. pneumoniae was resistant to the shear forces produced during nebulization, or perhaps the data from this study were based only on the survival of M. pneumoniae after aerosols had been generated and thus represented only the effects of desiccation. We had approximately a 0.5-log loss due to desiccation, which is comparable to a 55% survival rate.
The ability to establish M. pulmonis infections by aerosols allows several types of experiments to be performed that are otherwise not possible or that are confounded when intranasal inoculation is used. Perhaps the best examples are pulmonary clearance studies involving the classical Green and Kass model (12) . Intranasal infection from a 50-,ul volume is inadequate for this type of study, because only a few organisms reach the lungs. In addition, pulmonary clearance is known to be affected by anesthesia (11) and probably would also be compromised by the inoculation of a sufficient volume of media to ensure that adequate numbers of organisms reach the lungs. Both of these problems can be avoided with infective aerosols.
